https://www.fiercebiotech.com/biotech/german-merck-inks-vaccinex-pd-l1-anti-semaphorin-4d-igg4-combo-trial-deal
The word in cancer right now is combination, and Merck KGaA, coming in the same week it opened a new life science R&D collab center in
german mercklung cancerinkantipd
https://www.fiercebiotech.com/biotech/gsk-german-merck-s-4-2b-bintrafusp-alfa-drug-a-bust-fails-to-beat-king-keytruda-lung-cancer
A drug that Pfizer passed over but saw a revitalized cancer R&D-focused GlaxoSmithKline jump on for $4.2 billion has come up as a dud in a key trial pitting it...
german merckgskalfadrug